Hypogonadism

AUA Issues New Guidelines on Testosterone Deficiency

AUA Issues New Guidelines on Testosterone Deficiency

By

The new guidelines focus on accurate assessment and proper monitoring.

Dining Out Linked to Phthalates Exposure in US Population

Dining Out Linked to Phthalates Exposure in US Population

Teen high consumers of food outside the home had 55% higher androgen-disruptor levels.

Testosterone Therapy Guidelines Updated

Testosterone Therapy Guidelines Updated

By

Screening and treating all healthy men older than 65 years with testosterone is discouraged.

Low Sperm Count Linked With Cardiometabolic Conditions, Hypogonadism

Low Sperm Count Linked With Cardiometabolic Conditions, Hypogonadism

Low sperm counts linked to hypogonadism, higher BMI, hypertension, dyslipidemia, metabolic syndrome

Testosterone Replacement Therapy Does Not Raise CV Risks

Testosterone Replacement Therapy Does Not Raise CV Risks

By

A large study of middle-aged men found that testosterone replacement therapy is associated with a small but significant decrease in cardiovascular risk and an increased risk of obstructive sleep apnea.

Testosterone Therapy May Reduce PCa Risk in Hypogonadal Men

Testosterone Therapy May Reduce PCa Risk in Hypogonadal Men

By

In a study of hypogonadal men, those who received testosterone therapy had a lower incidence of prostate cancer than those who did not.

Testosterone Therapy May Lower Prostate Cancer Incidence

Testosterone Therapy May Lower Prostate Cancer Incidence

By

Hypogonadal men who received testosterone replacement therapy had a lower incidence of prostate cancer than those who did not, and their cancers were less severe.

Testosterone Patterns Predict Prostate Cancer Risk

Testosterone Patterns Predict Prostate Cancer Risk

By

The later a man's testosterone level dropped below 12.1 nmol/L, the lower his lifetime risk for prostate cancer.

Testosterone Rx May be Influenced by Provider, Site

Testosterone Rx May be Influenced by Provider, Site

Testosterone use was also more likely at sites located in the West vs the Northeast and for care received at a community-based outpatient clinic versus a medical center.

Hypogonadism Ups MetS Risk in Testicular Cancer Patients

Hypogonadism Ups MetS Risk in Testicular Cancer Patients

By

Hypogonadal testicular cancer survivors had 15 times higher odds of metabolic syndrome than their eugonadal counterparts.

Low Testosterone Tied to Anemia Risk in Men With Type 2 Diabetes

Low Testosterone Tied to Anemia Risk in Men With Type 2 Diabetes

In type 2 diabetic male patients, a low testosterone level was found to be associated with anemia. These findings are consistent with previous reports.

TRT Does Not Appear to Increase PCa Risk

TRT Does Not Appear to Increase PCa Risk

A population-based study showed no association between total prostate cancer risk and testosterone replacement therapy (TRT).

Testosterone Therapy Does Not Improve Cognitive Function

Testosterone Therapy Does Not Improve Cognitive Function

By

Study of older hypogonadal men does not support use of TRT to improve memory, according to researchers.

Anemia, Bone Density Improve With Testosterone Replacement

Anemia, Bone Density Improve With Testosterone Replacement

By

Older men on TRT versus placebo for 1 year had improved hemoglobin levels and volumetric bone mineral density and estimated bone strength.

Testosterone Replacement May Lower Cardiovascular Risks

Testosterone Replacement May Lower Cardiovascular Risks

By

In a large study, testosterone replacement therapy was associated with a 33% lower risk of cardiac and stroke events among hypogonadal men.

Normal Testosterone Range Defined

Normal Testosterone Range Defined

By

The normal range for total testosterone is 264 to 916 ng/dL for healthy men ages 19 to 39 with a body mass index below 30 kg/m2.

Venous Thromboembolism Risk Up in TRT Initiators

Venous Thromboembolism Risk Up in TRT Initiators

Risk peaks in the first 6 months of hormone treatment, but overall odds are low.

2 Percent Daily Testosterone Shows 6-Month Efficacy

2 Percent Daily Testosterone Shows 6-Month Efficacy

Once-daily T-sol administered for 6 months did not indicate new safety concerns, and the outcomes of low sex drive and low energy showed further improvement.

Hypogonadism Ups Progression Risk in Men With Low-Risk PCa

Hypogonadism Ups Progression Risk in Men With Low-Risk PCa

By

New findings have potential implications regarding patient selection for active surveillance.

FDA Adds Abuse Warning to All Testosterone Products

FDA Adds Abuse Warning to All Testosterone Products

The new FDA warning alerts prescribers to the abuse potential of testosterone.

FDA Adds New Testosterone Warnings

FDA Adds New Testosterone Warnings

By

Labeling changes will alert prescribers to the abuse potential of testosterone and the serious adverse effects.

TRT May Improve Cognition in Younger Hypogonadal Men

TRT May Improve Cognition in Younger Hypogonadal Men

By

Young men reported improvement in executive function after 2 years of TRT.

Study: mpMRI Findings in Prostate Cancer Patients Unaffected by TRT

Study: mpMRI Findings in Prostate Cancer Patients Unaffected by TRT

By

Results show that mpMRI and PI-RADSv2 score have a greater ability to detect prostate cancer progression after TRT compared with PSA.

Hypogonadism in Male HD Patients Linked to Poor ESA Response

Hypogonadism in Male HD Patients Linked to Poor ESA Response

By

Other risk factors include reduced muscle mass and lower levels of physical activity.

Testosterone Solution Effective for Hypogonadism Over 9 Months

Testosterone Solution Effective for Hypogonadism Over 9 Months

Once-daily 2% testosterone solution safe and effective for sex drive and energy.

Testosterone Treatment Aids Sexual Function of Older Men

Testosterone Treatment Aids Sexual Function of Older Men

Gel hormone treatment led to improved libido, increased sexual activity.

Testosterone Replacement Safe for Men With Prostate Cancer

Testosterone Replacement Safe for Men With Prostate Cancer

By

Findings emerge from a study of hypogonadal men who underwent radiation therapy, surgery, or active surveillance for prostate cancer.

Testosterone Therapy for Severe Hypogonadism Improves Sexual Function

Testosterone Therapy for Severe Hypogonadism Improves Sexual Function

By

The finding is from a 30-week study comparing testosterone undecanoate and placebo in hypogonadal men with type 2 diabetes.

Anabolic Steroids Easily Obtained Without Rx

Anabolic Steroids Easily Obtained Without Rx

By

Alert patients that use of performance-enhancing drugs can lead to erectile dysfunction and infertility.

Novel Oral Testosterone Shows Long-Term Safety, Tolerability

Novel Oral Testosterone Shows Long-Term Safety, Tolerability

By

In particular, no hepatic toxicities emerged during a 52-week phase 3 trial.

Sign Up for Free e-newsletters